Development of PCR assay for early detection of CMV infection in renal transplant recipients
Nephro-Urology Monthly: 3 (2); 106-108 Article Type: Research Article
May 18, 2010
August 28, 2010
E. Development of PCR assay for early detection of CMV infection in renal transplant recipients,
Online ahead of Print
Background: Cytomegalovirus (CMV) is an important viral pathogen in patients undergoing organ transplantation.
Objectives: We aimed to develop a molecular qualitative PCR assay for the detection of CMV DNA in clinical samples from renal transplant recipients.
Patients and Methods: Polymerase chain reaction (PCR) was performed for the assessment of CMV replication in two groups of renal transplant patients. Furthermore, the sensitivity of PCR for detection of CMV DNA from plasma relative to leukocyte was tested.
Results: CMV DNA was detected in 33 (25.9%) samples of 127 renal transplant patients. From 33 patients with positive PCR test, 20 patients had clinical symptoms and 13 (33.4%) of the patients had no clinical symptoms of disease. Also, the sensitivity of PCR assay for detection of CMV DNA from leukocyte relative to plasma is more.
Conclusions: The results suggest that The CMV PCR might be a useful tool for the early identification of patients at high risk of developing CMV disease. Furthermore the best sample for identify CMV infection is peripheral blood leukocytes (PBL).
Cytomegalovirus; Polymerase chain reaction; Renal transplantation; Peripheral blood leukocytes
© 0, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.